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The objective of this study was to establish whether or not
patients with unexplained recurrent abortion have an
increased incidence of haemostatic or metabolic abnor-
malities. Fifty-two patients with a history of unexplained
habitual abortion (two or more spontaneous abortions
before 16 weeks’ gestation) were tested for protein S,
protein C and antithrombin (AT) III deficiency, activated
protein C (aPC) resistance, hyperhomocysteinaemia and
anticardiolipin antibodies (ACA). The control group con-
sisted of 67 healthy women with a history of only uncomplic-
ated pregnancies. Blood samples were taken for measuring
protein S, protein C, AT III, ACA and activated protein C
resistance and a methionine loading test was performed.
Of the 46 patients tested for protein S deficiency, 8 (17.4%)
were positive. Of the 43 patients tested, two (4.7%) were
protein C deficient and none was AT III deficient. Of the
42 patients tested for ACA, eight (19.1%) had detectable
antibodies. Of the 44 patients tested for aPC resistance,
two (4.6%) were positive. Finally, 35 patients were tested
for hyperhomocysteinaemia and six (17.1%) were positive.
It was concluded that parous women with a history of
unexplained recurrent abortion have an increased incidence
of hyperhomocysteinaemia and a trend of increased incid-
ence of ACA can be found.
Key words: anticardiolipin antibodies/hyperhomocysteinaemia/
protein C and S deficiency/recurrent abortion
Introduction
Recurrent abortion affects 2–5% of the couples attempting
to reproduce (Coulam et al., 1997). The aetiology remains
unresolved in 24–60% of all cases of recurrent abortion
(Wouters et al., 1993).
Although it seems that certain disorders, for example chro-
mosome abnormalities, corpus luteum insufficiency, congenital
malformations of the uterus, systemic hypertension, diabetes
mellitus and hyper- or hypothyroidism may explain recurrent
pregnancy loss (Helio de Lima et al., 1993), these conditions
© European Society of Human Reproduction and Embryology 211
are rather infrequent. Recently, the relationship between coagu-
lation abnormalities (Preston et al., 1996) and metabolic
abnormalities (de Vries et al., 1997) has been described. This
leads to a pro-thrombotic state and an increased risk of fetal
loss after 16 weeks’ gestation. Wouters et al. (1993) found
evidence for a relation between metabolic abnormalities and
fetal loss before 16 weeks’ gestation. In this study we tried to
determine whether or not both underlying haemostatic and
metabolic abnormalities are associated with recurrent abortion.
Materials and methods
In the period between January 1995 and January 1996, 60 consecutive
patients with a history of recurrent abortion, defined as fetal loss
before 16 weeks’ gestational age, were screened by the following
tests: endometrium biopsy, IgG and IgM cytomegalovirus-antibodies,
karyotyping of the patient and partner, endocrine evaluations for
luteal insufficiency, thyroid dysfunction, diabetes mellitus and a
hysterosalpingography. In these 60 patients, we found three patients
with a uterus bicornis, one woman had a uterus subseptus, one woman
was exposed during intrauterine life to diethylstilboestrol (DES),
another woman had systemic lupus erythematosus and there were
two couples with a chromosome translocation.
In the remaining 52 women, no abnormalities were discovered in
these tests. These 52 patients with a history of unexplained recurrent
abortion were tested for the presence of protein S, protein C and
antithrombin III deficiency, activated protein C resistance, hyperhomo-
cysteinaemia (HHC) and immunoglobulin (Ig)G and IgM anticardio-
lipin antibodies (ACA).
Of the 52 women tested, 15 had experienced two spontaneous
abortions, 18 three, 11 four, four five, two six, one eight and one
patient 18 miscarriages. The total number of pregnancies was 186
(average 3.6). Not one of the abortions included in this study was of
the blighted ovum type. Embryo presence had been documented by
either ultrasound or inspection of the abortion material.
Of the 52 women included in the study, 18 had had a successful
pregnancy. Six of these 18 women had consecutive abortions.
As a control group for protein S deficiency, aPC resistance, HHC
and ACA, we used data from our recent study on underlying disorders
in pre-eclampsia (van Pampus et al., 1997). This control group
consisted of 67 healthy women with a normal menstrual cycle and
an obstetric history of only uncomplicated pregnancies.
As a reference for the incidence of AT III and protein C deficiency,
we used the data from the Leiden Thrombophilia Study (Miletich
et al., 1987; Tait et al., 1994).
The patients and controls did not use oral contraceptives or they
stopped its use at least 8 weeks before testing. None used vitamins,
known to influence homocysteine metabolism (van den Berg et al.,
1994), within at least a period of 6 months before performing a
methionine loading test. Patients and controls were tested in the
second half of a normal menstrual cycle for the presence of protein
S, protein C and AT III deficiency, activated protein C resistance,
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(HHC) and anticardiolipin antibodies. The 52 patients were tested at
least 10 weeks post-abortum.
Laboratory tests
Coagulation tests
Protein C activity was measured with Coamate® (Chromogenix,
Mo¨lndal, Sweden) protein C in a microplate system. The test was
performed according to the guidelines of the manufacturer. According
to the manufacturer the levels of protein C activity measured in 95
healthy individuals, 53 men and 42 women, aged between 19 and 64
years, are in the range of 70–149% (mean 103%, SD 17%) (Vinnazzer
and Pangraz, 1987). The normal value of protein C activity in a
control group of 30 healthy blood donors in our laboratory is 70–140%.
Total protein S antigen was measured by an enzyme-linked immuno-
sorbent assay with the use of rabbit antihuman anti-protein S from
Dakopatts (DAKO). This method has been described in detail by
Woodhams (1988). The test was performed according to the guidelines
of the manufacturer. The normal range for total protein S antigen is
70–130% according to Woodhams (1988) and DAKO. As an extra
control, every batch of patient samples was measured in parallel with
a sample of pooled plasma (30 healthy blood donors).
In our laboratory the normal value of total protein S antigen is
also 70–130%.
Antithrombin III activity was assayed with chromogenic substrate
S-2765 (Chromogenix) in a microplate system (Tollefsen, 1990). The
test was performed according to the guidelines of the manufacturer.
According to the manufacturer the reference values are 106% 6 19%
(2 SD, n 5 50; male 26, female 24).
In our laboratory the normal value of antithrombin III activity is
75–145%.
Activated protein C resistance was determined by the technique
described by Dahlba¨ck et al. (1993) and Koster et al. (1993). In
short, the resistance to activated protein C was determined by the
activated partial thromboplastin time performed in the absence and
presence of activated protein C. The results were expressed as the
ratio of the two values. The normal value of the activated protein C
sensitivity ratio is .2.0.
All patients with an abnormal coagulation test were retested after
6–12 weeks. They were considered to be positive only if the same
abnormality was found again at that time.
Anticardiolipin antibodies
In the current study ACA were determined by enzyme-linked immuno-
assay according to the directives of Harris (1990). Results were
evaluated spectrophotometrically (at 492 nm) and expressed as IgG
phospholipid units (GPL) and IgM phospholipid units (MPL). Results
were considered abnormal if GPL and/or MPL ù 10.
Hyperhomocysteinaemia
Hyperhomocysteinaemia was assessed both in the fasting state and
after methionine loading. After an overnight fast, EDTA blood for
determination of the fasting homocysteine concentration was obtained
at 0800 h. After 10 min of centrifugation at 1800 g, plasma was
stored at –300C until analysis. Subsequently, an oral dose of
L-methionine (0.1 g/kg body weight) was administered in orange
juice. The patients ate a standardized low-methionine breakfast and
lunch (containing 14 mg methionine/g protein) during the test. At 6
h after the methionine load a second blood sample was obtained
for determination of the post-load homocysteine concentration. All
measurements were performed within 1 week. Total (free plus protein-
bound) homocysteine concentrations (disulphide homocysteine plus
mixed disulphides) were measured with tri-N-butylphosphine used as
a reducing agent and ammonium 7-fluorobenzo-2-oxa-1,3-diazole-
4sulphonate used as the fluorochromophore, followed by high-per-
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Table I. Underlying disorders in 52 women with a history of unexplained
habitual abortion
Test Tested (no.) Positive (no.) Positive (%) Positive
controla ( %)
Prot S def 46 8 17.4 9c
Prot C def 43 2 4.7 0.1–0.3d
AT III def 43 0 0.0 0.1e
ACAb 42 8 19.1 7.5c
APC-R 44 2 4.6 1.5c
HHC 35 6 17.1 4.5c
Prot S def 5 protein S deficiency; ACA5 anticardiolipin antibodies IgG
and/orIgM; Prot C def 5 protein C deficiency; aPC-R 5 activated protein C
resistance; AT III def 5 antithrombin III deficiency; HHC 5
hyperhomocysteinaemia.
aControl, percentage of abnormal findings in normal populations.
b .10 GPL and/or MPL ACA.
cPampus van et al. (1997).
dMiletich et al. (1987).
eTait et al. (1994).
formance liquid chromatography with fluorescence detection (Mudd
et al., 1985; Ubbink et al., 1991).
Patients were considered hyperhomocysteinaemic if the homocyst-
eine concentration, measured 6 h after the methionine loading,
exceeded the 97.5 percentile in healthy premenopausal volunteers
(51 µ mol/l) (van Pampus et al., 1997).
Statistical analysis
Data were analysed using Fisher’s exact test. A two-sided P value
, 0.05 was considered to indicate a statistically significant difference.
Results
The overall results of the analysis of the 52 patients with a
history of unexplained recurrent abortion are presented in
Table I.
The mean (6SD) level of protein S in the eight patients
with a protein S deficiency was 62.5 6 5.15 %. Although the
incidence of protein S deficiency was higher in patients (17.4%)
than in the control population (9%), the difference was not
statistically significant, which may be due to small sample size.
The difference between the incidence of protein C and AT
III deficiency and aPC resistance in the patient population
versus the control group was not statistically significant.
Although there appears to be a marked difference in the
ACA regarding the patient population (19.1%) and the control
population (7.5%) this difference was not statistically signifi-
cant (P 5 0.12) which may also be due to the small sample
size. (Typical odds ratio 2.9; 95% CI: 0.88–9.6).
The difference concerning HHC in the overall patient group
versus the controls just failed to reach statistical significance
(P 5 0.059; odds ratio 4.4 and 95% CI: 1.03–18.8).
Of the 35 women tested for hyperhomocysteinaemia, 14
were parous and 21 were non-parous. In these subgroups, the
incidence of HHC was respectively 28.6% and 9.5%. The
control group consisted of only parous women, so the difference
between the parous patients (28.6%) and the parous controls
(4.5%) was statistically significant (P 5 0.015, odds ratio 8.5;
95% CI: 1.6–43.9).
Of the 52 women, 18 had had one successful pregnancy. Of
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Table II. The relationship between the number of abortions and the incidence of underlying abnormalities
Number of Number of Fully Abnormality found Abnormality found and
abortions women examined (number of consecutive abortions
patients, %) (number of patients)
2 15 7 2 (28.6) 2
3 18 12 7 (58.3) 7
4 11 8 5 (62.5) 3
5 4 4 3 (75) 1
6 2 2 1 0
8 1 1 1 0
18 1 1 1 0
these 18 women, eight women (44%) had an underlying
abnormality. Of the remaining 34 non-parous women, 15
women (44%) had an underlying abnormality, so there was no
difference between these subgroups.
In 29 (56%) women no abnormality was detected. However,
of these patients, only 15 patients had completed the full
protocol of six tests.
There were three women with a combination of underlying
abnormalities, one patient had hyperhomocysteinaemia and
high-positive ACA, one patient had hyperhomocysteinaemia
and protein S deficiency and the third patient had protein S
deficiency and activated protein C resistance.
The percentages of patients who were fully examined and
the presence of underlying abnormalities are shown in Table II.
Discussion
Recurrent abortion affects 2–5% of the population and because
its aetiology often remains unsolved, it is a tragic event for
both partners (Coulam et al., 1997).
In The Netherlands, recurrent abortion is traditionally defined
as three or more consecutive spontaneous abortions before 16
weeks’ gestation. However, in recent articles, a definition of
two or more spontaneous abortions is frequently used, because
doctors and couples tend to investigate sooner for potential
causes. In a previous study, this tendency appeared to be
justified by the observation of an equal distribution of possible
aetiological factors in couples with a history of two or more
miscarriages and those with three or more (Wouters et al.,
1993). The results of this study suggest that there is a positive
association between the number of failed pregnancies and the
chance of revealing haemostatic or metabolic abnormalities.
Obviously this is not the first study regarding unexplained
recurrent abortion and haemostatic and metabolic abnormalit-
ies. However, to our knowledge this is the first report where
an extended screening on both thrombotic and metabolic
factors was performed.
There are various hypotheses concerning the causes of
recurrent spontaneous abortion. There is much controversy
concerning the impact of psychological stress upon recurrent
abortion. A study by Bergant et al. (1997) showed that
psychological factors seem to be of subordinate importance as
a cause for recurrent spontaneous abortion. The detection of
the antiphospholipid syndrome as an aetiological cause for
recurrent abortion has substantiated the thrombosis theory
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of repeated fetal loss (Younis et al., 1997). Although the
pathophysiology of the antiphospholipid syndrome associated
thrombosis is not well characterized, antithrombotic treatments
employing the combination of aspirin and heparin have proved
to be effective in these women (Rai et al., 1997). In another
study, treatment with low-dose aspirin was evaluated (Tulppala
et al., 1997). The administration of aspirin caused a desirable
biochemical effect but it did not improve pregnancy outcome
in women with recurrent abortion with or without detectable
ACA. Other mechanisms must also be considered. The possibil-
ity of direct damage to the placenta by these antibodies is
supported by histologic observations of placentae from patients
who experienced intrauterine fetal death. The most significant
difference between placentae from patients with antiphospholi-
pid antibodies and patients without these antibodies was
decreased vasculo-syncytial membranes. Although the effect
on syncytial membranes was attributed to hypoxia secondary
to thrombosis, a counter hypothesis is that thrombosis occurred
secondary to syncytiotrophoblast damage (Rote, 1997).
Inherited thrombotic disorders, termed ‘familial thrombophi-
lia’, are the result of specific defects in the genes for plasma
coagulation proteins involved in heparin-antithrombin III and
protein C anticoagulant pathways. These are relatively rare
familial disorders that are usually inherited as autosomal
dominant disorders. Resistance to activated protein C is almost
always caused by a single point mutation in the factor V gene.
This new mutation has been termed factor V Leiden and is
also inherited autosomal dominant. Preston et al. (1996) has
substantiated the association between familial thrombophilia
and increased fetal loss, particularly stillbirth. Although in
studies of severe early onset pre-eclampsia the incidence of
aPC resistance as an underlying abnormality was found to be
increased (Dekker et al., 1995) this was not found in this
study on recurrent spontaneous abortion. Also Balasch et al.
(1997) found that first-trimester repeated abortion is not
associated with activated protein C resistance. The hypothesis
given by the authors is that the pregnancy-associated develop-
ment of resistance to activated protein C develops mainly after
14 weeks’ gestation and is more evident near term.
Protein S deficiency may also cause thrombo-embolism and
thus recurrent abortion. In our study we used precise testing
criteria. All patients were tested twice at least 10 weeks post-
abortum. They were considered to have protein S deficiency
only if the protein S antigen level was below 70% on both
occasions. The incidence of protein S deficiency in this
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population of patients with unexplained recurrent abortion is
about two times higher (not significant) than in the control
population.
We found that the incidence of hyperhomocysteinaemia in
the patient population was about four times higher (17.1%)
than the controls (4.5%). Hyperhomocysteinaemia is more
common in parous patients (28.6%) compared to non-parous
patients (9.5%). The study of Wouters et al. (1993) also
showed this discrepancy (33% versus 14%). Besides causing
thrombosis, hyperhomocysteinaemia could also cause recurrent
abortion because of its embryotoxicity (Unander et al., 1987).
A study by Su¨tterlin et al. (1997) evaluated the folate and
cobalamin serum levels in women with recurrent spontaneous
abortion. The levels showed no significant differences between
the patients and the controls. A negative association between
folate metabolism and parity has been suggested in the literature
(Stone et al., 1967). In this study we did not measure the
folate levels.
In three out of 52 women more than one abnormality was
found. There was no difference in the incidence of underlying
abnormalities in parous or non-parous women.
In summary, patients with a history of unexplained recurrent
abortion should be tested for the presence of protein S
deficiency, hyperhomocysteinaemia and anticardiolipin anti-
bodies, since these were the most common abnormalities found
in this patient group. Abnormalities were found in 44% of
these patients.
Finding these abnormalities may have an impact on general
health and may also influence management of subsequent
pregnancies.
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